499 related articles for article (PubMed ID: 8097759)
1. An HIV-1 envelope protein vaccine elicits a functionally complex human CD4+ T cell response that includes cytolytic T lymphocytes.
Stanhope PE; Liu AY; Pavlat W; Pitha PM; Clements ML; Siliciano RF
J Immunol; 1993 May; 150(10):4672-86. PubMed ID: 8097759
[TBL] [Abstract][Full Text] [Related]
2. Production of transmembrane and secreted forms of tumor necrosis factor (TNF)-alpha by HIV-1-specific CD4+ cytolytic T lymphocyte clones. Evidence for a TNF-alpha-independent cytolytic mechanism.
Liu AY; Miskovsky EP; Stanhope PE; Siliciano RF
J Immunol; 1992 Jun; 148(12):3789-98. PubMed ID: 1351088
[TBL] [Abstract][Full Text] [Related]
3. A vaccinia-gp160-based vaccine but not a gp160 protein vaccine elicits anti-gp160 cytotoxic T lymphocytes in some HIV-1 seronegative vaccinees.
Perales MA; Schwartz DH; Fabry JA; Lieberman J
J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Sep; 10(1):27-35. PubMed ID: 7648281
[TBL] [Abstract][Full Text] [Related]
4. Studies of the mechanism of cytolysis by HIV-1-specific CD4+ human CTL clones induced by candidate AIDS vaccines.
Miskovsky EP; Liu AY; Pavlat W; Viveen R; Stanhope PE; Finzi D; Fox WM; Hruban RH; Podack ER; Siliciano RF
J Immunol; 1994 Sep; 153(6):2787-99. PubMed ID: 7915742
[TBL] [Abstract][Full Text] [Related]
5. Cytokines from vaccine-induced HIV-1 specific cytotoxic T lymphocytes: effects on viral replication.
Bollinger RC; Quinn TC; Liu AY; Stanhope PE; Hammond SA; Viveen R; Clements ML; Siliciano RF
AIDS Res Hum Retroviruses; 1993 Nov; 9(11):1067-77. PubMed ID: 7906131
[TBL] [Abstract][Full Text] [Related]
6. Preferential V beta usage by cytotoxic T cells cross-reactive between two epitopes of HIV-1 gp160 and degenerate in class I MHC restriction.
Shirai M; Vacchio MS; Hodes RJ; Berzofsky JA
J Immunol; 1993 Aug; 151(4):2283-95. PubMed ID: 7688397
[TBL] [Abstract][Full Text] [Related]
7. HIV-1 soluble antigens induced CD8+ cytotoxic T-cell responses in an immunized individual.
Achour A; Moukrim Z; Picard O; Bizzini B; Burny A; Zagury D
Cell Mol Biol (Noisy-le-grand); 1995 May; 41(3):395-400. PubMed ID: 7580833
[TBL] [Abstract][Full Text] [Related]
8. Helper-cytotoxic T lymphocyte (CTL) determinant linkage required for priming of anti-HIV CD8+ CTL in vivo with peptide vaccine constructs.
Shirai M; Pendleton CD; Ahlers J; Takeshita T; Newman M; Berzofsky JA
J Immunol; 1994 Jan; 152(2):549-56. PubMed ID: 8283036
[TBL] [Abstract][Full Text] [Related]
9. Human CD4+ cytolytic T lymphocyte responses to a human immunodeficiency virus type 1 gp160 subunit vaccine.
Stanhope PE; Clements ML; Siliciano RF
J Infect Dis; 1993 Jul; 168(1):92-100. PubMed ID: 8099941
[TBL] [Abstract][Full Text] [Related]
10. Comparative clonal analysis of human immunodeficiency virus type 1 (HIV-1)-specific CD4+ and CD8+ cytolytic T lymphocytes isolated from seronegative humans immunized with candidate HIV-1 vaccines.
Hammond SA; Bollinger RC; Stanhope PE; Quinn TC; Schwartz D; Clements ML; Siliciano RF
J Exp Med; 1992 Dec; 176(6):1531-42. PubMed ID: 1460417
[TBL] [Abstract][Full Text] [Related]
11. Antagonism of vaccine-induced HIV-1-specific CD4+ T cells by primary HIV-1 infection: potential mechanism of vaccine failure.
Kent SJ; Greenberg PD; Hoffman MC; Akridge RE; McElrath MJ
J Immunol; 1997 Jan; 158(2):807-15. PubMed ID: 8992998
[TBL] [Abstract][Full Text] [Related]
12. Recombinant human immunodeficiency Pr55gag virus-like particles presenting chimeric envelope glycoproteins induce cytotoxic T-cells and neutralizing antibodies.
Deml L; Schirmbeck R; Reimann J; Wolf H; Wagner R
Virology; 1997 Aug; 235(1):26-39. PubMed ID: 9300034
[TBL] [Abstract][Full Text] [Related]
13. Clonal analysis of T-cell responses to the HIV-1 envelope proteins in AIDS vaccine recipients.
Siliciano RF; Bollinger RC; Callahan KM; Hammond SA; Liu AY; Miskovsky EP; Rowell JF; Stanhope PE
AIDS Res Hum Retroviruses; 1992 Aug; 8(8):1349-52. PubMed ID: 1361352
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of cytotoxic T cell responses to candidate HIV-1 vaccines in HIV-1-uninfected individuals.
McElrath MJ; Corey L; Greenberg PD
AIDS Res Hum Retroviruses; 1994; 10 Suppl 2():S69-72. PubMed ID: 7865336
[TBL] [Abstract][Full Text] [Related]
15. Broad recognition of cytotoxic T cell epitopes from the HIV-1 envelope protein with multiple class I histocompatibility molecules.
Shirai M; Pendleton CD; Berzofsky JA
J Immunol; 1992 Mar; 148(6):1657-67. PubMed ID: 1371784
[TBL] [Abstract][Full Text] [Related]
16. Cytotoxic T cell repertoire selection. A single amino acid determines alternative class I restriction.
Bergmann CC; Tong L; Cua RV; Sensintaffar JL; Stohlman SA
J Immunol; 1994 Jun; 152(12):5603-12. PubMed ID: 7515908
[TBL] [Abstract][Full Text] [Related]
17. CD4+ T cell clones isolated from human renal cell carcinoma possess the functional characteristics of Th2 helper cells.
Schoof DD; Terashima Y; Peoples GE; Goedegebuure PS; Andrews JV; Richie JP; Eberlein TJ
Cell Immunol; 1993 Aug; 150(1):114-23. PubMed ID: 8102084
[TBL] [Abstract][Full Text] [Related]
18. Saponin adjuvant enhancement of antigen-specific immune responses to an experimental HIV-1 vaccine.
Wu JY; Gardner BH; Murphy CI; Seals JR; Kensil CR; Recchia J; Beltz GA; Newman GW; Newman MJ
J Immunol; 1992 Mar; 148(5):1519-25. PubMed ID: 1538134
[TBL] [Abstract][Full Text] [Related]
19. HIV-1 env DNA vaccine administered to rhesus monkeys elicits MHC class II-restricted CD4+ T helper cells that secrete IFN-gamma and TNF-alpha.
Lekutis C; Shiver JW; Liu MA; Letvin NL
J Immunol; 1997 May; 158(9):4471-7. PubMed ID: 9127013
[TBL] [Abstract][Full Text] [Related]
20. Induction of CD4+ human cytolytic T cells specific for HIV-infected cells by a gp160 subunit vaccine.
Orentas RJ; Hildreth JE; Obah E; Polydefkis M; Smith GE; Clements ML; Siliciano RF
Science; 1990 Jun; 248(4960):1234-7. PubMed ID: 2190315
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
